Efficacy of Ravuconazole in Treatment of Mucosal Candidosis in SCID Mice
A model of orogastric candidosis in SCID mice, which mimics disease seen in AIDS patients, was used to evaluate ravuconazole in comparison with fluconazole for treatment. Mice were infected orally with Candida albicans and received either no treatment or oral treatment once daily for 12 days with 1,...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
2001
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90849/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709320/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3433-3436.2001 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|